Common Stock, Shares, Outstanding of PLUS THERAPEUTICS, INC. from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
PLUS THERAPEUTICS, INC. quarterly Common Stock, Shares, Outstanding history and change rate from Q4 2010 to Q3 2025.
  • PLUS THERAPEUTICS, INC. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 132M shares, a 2132% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

PLUS THERAPEUTICS, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 132M +126M +2132% 30 Sep 2025 10-Q 30 Oct 2025
Q2 2025 92.2M +86.5M +1516% 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 17M +12.7M +299% 31 Mar 2025 10-Q 30 May 2025
Q4 2024 5.9M +1.45M +32.7% 31 Dec 2024 10-Q 30 Oct 2025
Q3 2024 5.9M +1.37M +30.4% 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 5.7M +2.82M +98.1% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 4.26M -31.9M -88.2% 31 Mar 2024 10-Q 15 May 2024
Q4 2023 4.44M +2.2M +98.4% 31 Dec 2023 10-K 31 Mar 2025
Q3 2023 4.52M -28M -86.1% 30 Sep 2023 10-Q 31 Oct 2023
Q2 2023 2.88M -19.6M -87.2% 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 36.1M +13.9M +62.7% 31 Mar 2023 10-Q 20 Apr 2023
Q4 2022 2.24M -13.3M -85.6% 31 Dec 2022 10-K 05 Mar 2024
Q3 2022 32.6M +17.2M +112% 30 Sep 2022 10-Q 20 Oct 2022
Q2 2022 22.5M +10.4M +85.9% 30 Jun 2022 10-Q 21 Jul 2022
Q1 2022 22.2M +12M +118% 31 Mar 2022 10-Q 21 Apr 2022
Q4 2021 15.5M +8.76M +130% 31 Dec 2021 10-K 23 Feb 2023
Q3 2021 15.4M +10.8M +235% 30 Sep 2021 10-Q 21 Oct 2021
Q2 2021 12.1M +7.81M +183% 30 Jun 2021 10-Q 22 Jul 2021
Q1 2021 10.2M +6.3M +162% 31 Mar 2021 10-Q 22 Apr 2021
Q4 2020 6.75M +2.87M +73.9% 31 Dec 2020 10-K 24 Feb 2022
Q3 2020 4.59M +1.75M +61.6% 30 Sep 2020 10-Q 22 Oct 2020
Q2 2020 4.27M +3.98M +1341% 30 Jun 2020 10-Q 10 Aug 2020
Q1 2020 3.88M +3.44M +786% 31 Mar 2020 10-Q 14 May 2020
Q4 2019 3.88M +3.58M +1208% 31 Dec 2019 10-K 22 Feb 2021
Q3 2019 2.84M -8.85M -75.7% 30 Sep 2019 10-Q 14 Nov 2019
Q2 2019 297K -5.88M -95.2% 30 Jun 2019 10-Q 15 Aug 2019
Q1 2019 438K -61.2M -99.3% 31 Mar 2019 8-K 10 Sep 2019
Q4 2018 297K +181K +156% 31 Dec 2018 10-K 30 Mar 2020
Q3 2018 11.7M -23M -66.3% 30 Sep 2018 10-Q 14 Nov 2018
Q2 2018 6.18M -27.2M -81.5% 30 Jun 2018 10-Q 14 Aug 2018
Q1 2018 61.6M +37.8M +159% 31 Mar 2018 10-Q 11 May 2018
Q4 2017 116K -21.6M -99.5% 31 Dec 2017 8-K 10 Sep 2019
Q3 2017 34.7M +14.2M +69.4% 30 Sep 2017 10-Q 09 Nov 2017
Q2 2017 33.3M +12.8M +62.6% 30 Jun 2017 10-Q 11 Aug 2017
Q1 2017 23.8M -176M -88.1% 31 Mar 2017 10-Q 12 May 2017
Q4 2016 21.7M +8.7M +66.9% 31 Dec 2016 10-K 09 Mar 2018
Q3 2016 20.5M -138M -87.1% 30 Sep 2016 10-Q 09 Nov 2016
Q2 2016 20.5M -130M -86.4% 30 Jun 2016 10-Q 05 Aug 2016
Q1 2016 200M +85.9M +75.3% 31 Mar 2016 10-Q 09 Nov 2016
Q4 2015 13M -86.3M -86.9% 31 Dec 2015 10-K 24 Mar 2017
Q3 2015 158M +74.9M +89.6% 30 Sep 2015 10-Q 06 Nov 2015
Q2 2015 151M +71.4M +89.8% 30 Jun 2015 10-Q 10 Aug 2015
Q1 2015 114M +38.6M +51.2% 31 Mar 2015 10-Q 11 May 2015
Q4 2014 99.3M +28M +39.3% 31 Dec 2014 10-K 11 Mar 2016
Q3 2014 83.6M +16.3M +24.2% 30 Sep 2014 10-Q 07 Nov 2014
Q2 2014 79.5M +12.3M +18.3% 30 Jun 2014 10-Q 11 Aug 2014
Q1 2014 75.5M +8.29M +12.3% 31 Mar 2014 10-Q 12 May 2014
Q4 2013 71.3M +5.39M +8.18% 31 Dec 2013 10-K 16 Mar 2015
Q3 2013 67.3M +10.7M +18.9% 30 Sep 2013 10-Q 12 Nov 2013
Q2 2013 67.2M +8.53M +14.5% 30 Jun 2013 10-Q 09 Aug 2013
Q1 2013 67.2M +8.74M +15% 31 Mar 2013 10-Q 10 May 2013
Q4 2012 65.9M +9.32M +16.5% 31 Dec 2012 10-K 14 Mar 2014
Q3 2012 56.6M +1.76M +3.21% 30 Sep 2012 10-Q 09 Nov 2012
Q2 2012 58.7M +6.24M +11.9% 30 Jun 2012 10-Q 09 Aug 2012
Q1 2012 58.4M 31 Mar 2012 10-Q 10 May 2012
Q4 2011 56.6M +4.64M +8.93% 31 Dec 2011 10-K 15 Mar 2013
Q3 2011 54.8M 30 Sep 2011 10-Q 08 Nov 2011
Q2 2011 52.5M 30 Jun 2011 10-Q 09 Aug 2011
Q4 2010 52M 31 Dec 2010 10-K/A 07 Sep 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.